Navigating Cancer raises $26M Series D from Merck GHIF and TT Capital to expand oncology patient-engagement platform

Seattle startup Navigating Cancer raised $26 million in a Series D led by Merck Global Health Innovation Fund and TT Capital Partners to expand its oncology patient engagement software and improve treatment adherence and outcomes.

No comments yet.